DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20161708

Efficacy of prophylactic tranexamic acid in reducing blood loss during and after caesarean section

Bhavana G., Abhishek MV, Suneeta Mittal

Abstract


Background: In India, caesarean section rate is rising, so the impact of prophylactic injection of tranexamic acid in decreasing blood loss during caesarean section would be more beneficial in terms of having minimal blood loss intra operatively and post operatively and thereby decreasing maternal morbidity. The objective of the study was to evaluate the efficacy of prophylactic tranexamic acid in reducing blood loss during and after caesarean section.

Methods: A randomized controlled trial among 200 term women with singleton pregnancy for a period of 2 years was carried out. They were randomized by computer generated numbers into two groups: study group-100 women receiving prophylactic tranexamic acid women and control group-100 women receiving placebo.

Results: The blood loss during caesarean section was less in the tranexamic acid group compared to the placebo group. Similarly blood loss measured 6hrs after caesarean section was less in the tranexamic acid group compared to placebo group. 20-40min before the time of incision was the ideal time gap for administering the injection tranexamic acid for its optimum efficacy. Tranexamic acid group had lesser requirement of uterotonic when compared to placebo, but need for blood transfusion was similar in both the groups. Greater fall in the hemoglobin and haematocrit occurred in placebo group compared to tranexamic acid group. No changes in the post-operative vitals or side effects were seen in the tranexamic acid group. Even no change in birth weight and Apgar scores was seen in neonates of tranexamic acid group.

Conclusions: Injection tranexamic acid is the, antifibrinolytic agent that can be used for prophylactic administration before caesarean section for decreasing blood loss during surgery.


Keywords


Tranexamic acid, Blood loss, Caesarean section

Full Text:

PDF

References


World Health Organization, U.N.C.F, United Nations Population Fund, World Bank: Maternal Mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA, and The World Bank. Geneva. 2007.

Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti fibrinolytic agents in post-partum haemorrhage: asystematic review. BMC Pregnancy Childbirth. 2009;9:29:1-6.

Department of Reproductive Health and Research, World Health Organization: WHO Guidelines for the Management of Postpartum Hemorrhage and Retained Placenta. Geneva: WHO Library Cataloguing in-Publication Data NLM classification: WQ 330.

Pfanner G, Kilgert K. Haemorrhagic complications in obstetrics. H├Ąmostaseologie. 2006;26(3 Suppl1):S56-63.

Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. PPH Study Group: The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266-73.

Levy JH, Dutton RP, Hemphill JC, Shander A, Cooper D, Paidas MJ. Hemostasis Summit Participants: Multidisciplinary approach to the challenge of hemostasis. Anesth Analg. 2010;110:354-64.

Wellington K, Wagstaff AJ. Tranexamic acid: Review of its use in management of menorrhagia. Drugs. 2003;63:1417.

Soramachi T. Methods of antifibrinolytics administration and their side effects. Neurosurgery 2006;58:E1003.

Ido K, Neo M, Asada Y. Reduction of blood loss using using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg. 2000;120:518-20.

Gohel M, Patel P, Gupta A, Desai P. Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: A randomized case controlled prospective study. J Obstet Gynecol India. 2007;57(3):227-30.

Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T. Efficacy of tranexamic acid in reducing blood loss after cesarean section The Journal of Maternal-Fetal and Neonatal Medicine. 2009;22(1):72-5.

Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynecol Obstet. 2011;115(3):224-6.

Gungorduk K, Yildirm G, Asicio─člu O, Gungorduk OS, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study Am J Perinatol. 2011;28(3):233-40.

Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood lossreduced by tranexamic acid during and after caesarean section: a multicenter, randomized trial. Eur J Obstet Gynecol Reprod Biol. 2004;112:154-7.

Ministry of Health and Family Welfare, Govt of India.NFHS-3, 2005-06: India Vol 1. New Delhi: MOFHW, 2007.

Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acidin reducing postpartum blood loss: a randomized, comparative,multicenter trial. Zhonghua Fu Chan Ke Za Zhi. 2001;36:590-2.